A world-first discovery has revealed special immune cells called ‘killer T cells’ in older adults, directed against influenza viruses, closely resemble those found in newborns and children, but struggle to recognise infected cells – a finding that unlocks the potential for the development of better vaccines and therapies tailored to different age groups.
Pharmalittle: We’re reading about menopause treatments, Novo plans for Wegovy in India, and more
Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting over the Pharmalot campus, where
December 3, 2024